Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent protecting this compound.
Drug patent litigation for SUGAMMADEX SODIUM.
This ingredient has forty patent family members in thirty countries.
Three suppliers are listed for this compound. There are three tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com